Synergistic effect of the TLR5 agonist CBLB502 and its downstream effector IL-22 against liver injury
published in: Cell Death and Disease
date of publication: 2021-04-06
Cites articles
There is nothing here
Article - wd:Q112585863
There is nothing here
Article - wd:Q112585863